Cargando…
Hepatitis C Treatment and Barriers to Eradication
Current treatment for chronic hepatitis C (CHC) is highly efficacious, well-tolerated, and of short duration for the majority of patients. Despite the dramatic advances in therapy, there remain several barriers to disease eradication. These include deficiencies in screening, diagnosis, and access to...
Autores principales: | Konerman, Monica A, Lok, Anna S F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288596/ https://www.ncbi.nlm.nih.gov/pubmed/27657495 http://dx.doi.org/10.1038/ctg.2016.50 |
Ejemplares similares
-
Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C
por: Konerman, Monica A., et al.
Publicado: (2017) -
Noninvasive Monitoring of Liver Disease Regression after Hepatitis C Eradication Using Gadoxetic Acid-Enhanced MRI
por: Haider, Lukas, et al.
Publicado: (2018) -
Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
por: Pisaturo, Mariantonietta, et al.
Publicado: (2019) -
Towards the elimination and eradication of hepatitis B
por: Dusheiko, Geoffrey
Publicado: (2015) -
Personalized treatment of hepatitis B
por: Lok, Anna S.
Publicado: (2015)